NeuroOne CEO Dave Rosa talks uplisting on Nasdaq, upcoming advancements
December 14, 2021 at 16:38 PM EST
NeuroOne commercialized its first diagnostic brain-scan product in January and uplisted to the Nasdaq in May.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|